Where does Marina Biotech, Inc. rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Marina Biotech, Inc. ranks #18,877 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Marina Biotech, Inc. hold?

Marina Biotech, Inc. holds 15 US utility patents granted between 2015 and 2018, spanning 11 technology areas.

What is Marina Biotech, Inc.'s Innovation Score?

Marina Biotech, Inc. has an Innovation Score of 29.7 out of 100 (32nd percentile of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

Is Marina Biotech, Inc.'s patent grant rate increasing or decreasing?

Marina Biotech, Inc.'s recent grant velocity is -100% compared to the prior five-year period (grant years, not application filing dates). Grant activity has slowed relative to earlier years.

What does claim depth mean for Marina Biotech, Inc.'s patents?

Marina Biotech, Inc.'s patents average 14.1 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Marina Biotech, Inc. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView US Corporation

Marina Biotech, Inc.

Q: What technology areas does Marina Biotech, Inc. focus on?

Marina Biotech, Inc.'s top technology area is C12N (Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media) with 13 patents, ranking #809 of 4,144 assignees active in that subclass. Grants appear in 11 CPC subclasses total.

USPTO PatentsView assignee record - 15 granted patents across 11 technology areas, recorded in grant years 2015–2018. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: C12N (Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Marina ranks #18,877 of 49,997 tracked US assignees by granted-patent volume, with 15 patents across 11 technology areas.

#18,877
of 49,997 US assignees by volume: 32nd percentile
by Innovation Score (29.7/100): 14.1
avg claims per patent: -100%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R18877 · US Corporation #18,877 · 15 grants

GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-FOCUS · INNOV-THIN · CLAIMS-RICH · TYPE-USCORP · VEL-DROP · BOOK-FULL

GRANTS-MICRO 15 grants
MID-PACK #18,877/49,997
PHOTO-FINISH Maax Bath
CPC-FOCUS C12N · 11 areas
INNOV-THIN 29.7/100
CLAIMS-RICH 14.1 claims/avg
TYPE-USCORP US Corporation
VEL-DROP -100% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Maax Bath Inc. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Marina’s 29.7 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 9.6 pts (32%) Velocity 0.0 pts (0%) Breadth 11.7 pts (39%) Claim depth 8.4 pts (28%)

Qualcomm Incorporated · highest

85
Betterguards… · near

30
Marina Biotech · this assignee

30
CB Innovations · near

30
Zama Japan · near

30
CrunchLabs · near

30
3D Lighting… · lowest

7

What this shows Marina's Innovation Score is 29.7/100 (32nd percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Marina?

Each dot is one of Marina’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Marina’s own 14.1 claims/patent is at or below the 16.2 median for these volume peers. Volume here does not track with deeper claims; several lower-volume peers claim more thoroughly per patent.

Marina vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Marina's grants concentrate

Marina Biotech, Inc. is a focused PatentsView assignee: 11 CPC subclasses with 86.7% of grants classified under C12N (Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media). Peak complete grant year is 2017 (6 grants) versus a trough of 2 in 2016. By volume, Marina sits between Maax Bath Inc. and Melaleuca, Inc..

Maax Bath

15
Majen Tech

15
Mangrove Water

15
Marelli Cabin Com…

15
Mcscience

15
Medac Gesellschaf…

15
Medical Instrumen…

15
Melaleuca

15
Marina Biotech ◀

15

What this shows Marina holds 15 patents at rank #18,889, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Marina

By rank, the assignees closest to #18,889 in granted patent volume.

Leaders in C12N (Microorganisms OR Enzymes)

Other assignees with the most granted patents in Marina's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for Marina, neither rank-band nor same-CPC leaders (those blocks stay above). In C12N (Microorganisms OR Enzymes), Marina ranks #809 of 4,144 assignees by patent count in that subclass.

Similar innovation score

Nearest assignees by Innovation Score (30 here).

Betterguards Technology GmbH 30 CB Innovations, LLC 30 Zama Japan Kabushiki Kaisha 30 CrunchLabs LLC 30

Marina's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

30 32nd percentile higher than 32% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2015–2018

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table

Marina Biotech, Inc. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2015	5	33.3%
2016	2	13.3%
2017	6	40.0%
2018	2	13.3%

Which technologies does Marina Biotech, Inc. patent most?

C12N - Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media 13

A61P - Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations 12

A61K - Preparations FOR Medical, Dental OR Toiletry Purposes 11

C07K - Peptides 4

C07D - Heterocyclic Compounds 3

C07C - Acyclic OR Carbocyclic Compounds 3

C12Y - Enzymes 2

Y02P - Climate Change Mitigation Technologies IN THE Production OR Processing OF Goods 1

C07H - SUGARS; Derivatives THEREOF; NUCLEOSIDES; NUCLEOTIDES; Nucleic Acids 1

C07F - Acyclic, Carbocyclic OR Heterocyclic Compounds Containing Elements Other Than Carbon, Hydrogen, Halogen, Oxygen, Nitrogen, Sulfur, Selenium OR Tellurium 1

Y10T - Technical Subjects Covered BY Former US Classification 1

Top 11 of 11 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Marina Biotech, Inc.'s patent record in context - here's where to go next.

Marina Biotech, Inc.'s lead technology class is C12N (Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media), 86.7% of its portfolio - see every assignee active in that class. Explore C12N
Ranked #18,877 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Marina Biotech, Inc. against Maax Bath Inc., an assignee filing at a similar volume. Compare portfolios
Innovation Score of 29.7/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.